5
6

Small Biotech Innovation Act

7/2/2025, 1:51 AM

Summary of Bill S 1930

The bill titled "A bill to amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exemption the Medicare drug price negotiation program" was introduced in the 119th Congress on June 3, 2025.

Current Status of Bill S 1930

Bill S 1930 is currently in the status of Bill Introduced since June 3, 2025. Bill S 1930 was introduced during Congress 119 and was introduced to the Senate on June 3, 2025.  Bill S 1930's most recent activity was Read twice and referred to the Committee on Finance. as of June 3, 2025

Bipartisan Support of Bill S 1930

Total Number of Sponsors
7
Democrat Sponsors
0
Republican Sponsors
7
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 1930

Primary Policy Focus

Health

Alternate Title(s) of Bill S 1930

A bill to amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exemption the Medicare drug price negotiation program.
A bill to amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exemption the Medicare drug price negotiation program.

Comments

Angie Franklin profile image

Angie Franklin

654

8 months ago

I respectfully disagree with this bill. It may impact my access to affordable medications.